Eris Biotech
PrivateLast Round
Accelerator
Feb 1, 2024
Total Funding Raised
$500,000
Company Overview
Eris Biotech is a biotechnology company developing small-molecule cancer therapeutics that inhibit immune suppression to re-engage the patient's immune system against solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eris Biotech Comparables
Compare Eris Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Keyhole Therapeutics | 91% | |
| Peel Therapeutics | 70% | |
| Vivace Therapeutics | 69% |
Eris Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Feb 1, 2024 |
Eris Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Orange Collective | Accelerator |
| Y Combinator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2024
$500K round led by Y Combinator
Eris Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Eris Biotech's valuation, stock price, and market status.
Is Eris Biotech a public or private company?
Eris Biotech is a private company.
What is the current stock price of Eris Biotech?
Eris Biotech is a private company with no public stock price. No recent secondary market data is available.
How much is Eris Biotech worth (valuation)?
Valuation information for Eris Biotech is not publicly available.
Can I buy Eris Biotech stock?
Eris Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Eris Biotech's last funding round?
Eris Biotech's most recent funding round was Seed on February 8, 2024.
Who are the main investors in Eris Biotech?
Key investors in Eris Biotech include Y Combinator.
Will Eris Biotech IPO soon?
No public IPO plans have been announced for Eris Biotech.
How can I track Eris Biotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Eris Biotech's secondary market activity and sign up for updates.